HOS, a human homolog of Slimb, forms an SCF complex with Skp1 and Cullin1 and targets the phosphorylation-dependent degradation of IκB and β-catenin

被引:160
作者
Fuchs, SY
Chen, A
Xiong, Y
Pan, ZQ
Ronai, Z
机构
[1] CUNY Mt Sinai Sch Med, Derald H Ruttenberg Canc Ctr, New York, NY 10029 USA
[2] Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA
关键词
ubiquitination; SCF E2 ligase; I kappa B; beta-catenin; phosphorylation; degradation;
D O I
10.1038/sj.onc.1202760
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
SCF E3 ubiquitin ligases mediate ubiquitination and proteasome-dependent degradation of phosphorylated substrates. We identified a human F-box/WD40 repeats protein (HOS), which is homologous to Slimb/h beta TrCP. Being a part of SCF complex with Skp1 and Cullin1, HOS specifically interacted with the phosphorylated I kappa B and beta-catenin, targeting these proteins for proteasome-dependent degradation in vivo, This targeting required Cullin1 as expression of a mutant Cullin1 abrogated the degradation of I kappa B and of beta-catenin. Mutant HOS which lacks the F-box blocked TNF alpha-induced degradation of I kappa B as well as GSK3 beta-mediated degradation of beta-catenin. This mutant also inhibited NF-kappa B transactivation and increased the beta-catenine-dependent transcription activity of Tcf. These results demonstrate that SCFHOS E3 ubiquitin ligase regulate both NF-kappa B and beta-catenin signaling pathways.
引用
收藏
页码:2039 / 2046
页数:8
相关论文
共 37 条
  • [1] beta-catenin is a target for the ubiquitin-proteasome pathway
    Aberle, H
    Bauer, A
    Stappert, J
    Kispert, A
    Kemler, R
    [J]. EMBO JOURNAL, 1997, 16 (13) : 3797 - 3804
  • [2] SKP1 connects cell cycle regulators to the ubiquitin proteolysis machinery through a novel motif, the F-box
    Bai, C
    Sen, P
    Hofmann, K
    Ma, L
    Goebl, M
    Harper, JW
    Elledge, SJ
    [J]. CELL, 1996, 86 (02) : 263 - 274
  • [3] BROCKMAN JA, 1995, MOL CELL BIOL, V15, P2809
  • [4] SIGNAL-INDUCED SITE-SPECIFIC PHOSPHORYLATION TARGETS I-KAPPA-B-ALPHA TO THE UBIQUITIN-PROTEASOME PATHWAY
    CHEN, ZJ
    HAGLER, J
    PALOMBELLA, VJ
    MELANDRI, F
    SCHERER, D
    BALLARD, D
    MANIATIS, T
    [J]. GENES & DEVELOPMENT, 1995, 9 (13) : 1586 - 1597
  • [5] A cytokine-responsive I kappa B kinase that activates the transcription factor NF-kappa B
    DiDonato, JA
    Hayakawa, M
    Rothwarf, DM
    Zandi, E
    Karin, M
    [J]. NATURE, 1997, 388 (6642) : 548 - 554
  • [6] Phosphorylation of insulin receptor substrate 1 by glycogen synthase kinase 3 impairs insulin action
    EldarFinkelman, H
    Krebs, EG
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (18) : 9660 - 9664
  • [7] The role of protein stability in the cell cycle and cancer
    Elledge, SJ
    Harper, JW
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 1998, 1377 (02): : M61 - M70
  • [8] A complex of Cdc4p, Skp1p, and Cdc53p/cullin catalyzes ubiquitination of the phosphorylated CDK inhibitor Sic1p
    Feldman, RMR
    Correll, CC
    Kaplan, KB
    Deshaies, RJ
    [J]. CELL, 1997, 91 (02) : 221 - 230
  • [9] MEKK1/JNK signaling stabilizes and activates p53
    Fuchs, SY
    Adler, V
    Pincus, MR
    Ronai, Z
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (18) : 10541 - 10546
  • [10] Downregulation of β-catenin by human Axin and its association with the APC tumor suppressor, β-catenin and GSK3β
    Hart, MJ
    de los Santos, R
    Albert, IN
    Rubinfeld, B
    Polakis, P
    [J]. CURRENT BIOLOGY, 1998, 8 (10) : 573 - 581